Trial intelligence / Profile preview

Insulin Bolus for High Fat Meals

NCT02248454Completed

Sponsor
Joslin Diabetes Center
Start
Sep 2014
Primary completion
Apr 2015
Modality
Recombinant Proteins and Enzymes
01

Overview

Open-label, single-arm trial of insulin lispro in type 1 diabetes mellitus (T1D), sponsored by Joslin Diabetes Center. Primary endpoint: Predictors of fat sensitivity. Started Sep 2014; status: completed.

02

Drugs

insulin lispro
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT02248454.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02248454.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call